Circulating Tumor Cells and Cell-Free DNA during Three or Six Months of Adjuvant Chemotherapy in Stage III Colorectal Cancer
Year: 2026
Type: article
Abstract: Background: The optimal duration of adjuvant chemotherapy for stage III colorectal cancer (CRC) remains uncertain following the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) trial collaboration, while the ... | Find, read and cite all the research you need on Tech Science Press
Institutions: University of Crete, University Hospital of Heraklion
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Award: G2614925313
OpenAlex ID: W7225620705
